#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranous Activated PI3 kinase delta syndrome Fusarium infection Pulmonary alveolar haemorrhage Acquired ATTR amyloidosis Chronic graft versus host disease in liver Metastases to peritoneum Neurodegenerative disorder Small intestine leiomyosarcoma Bladder cancer Lupus nephritis Paget's disease of the vulva Philadelphia chromosome positive Acute myeloid leukaemia recurrent Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Basic Information Castleman’s disease – Treatment Hypereosinophilic syndrome – Diagnostics Chondrosarcoma metastatic – Diagnostics Castleman’s disease – Life with Disease Systemic mastocytosis Waldenstrom’s macroglobulinaemia – Treatment Osteosarcoma – Trials in Disease Pemphigoid Malignant fibrous histiocytoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bbp-398 Rapcabtagene Autoleucel Potassium Canrenoate SELTOREXANT Alrefimotide S-241656 Dimethyl Fumarate Testosterone Undecanoate 2,4 DICHLOROBENZYL ALCOHOL Kk8123 Quavonlimab Garadacimab Paclitaxel Obaluronate Tozorakimab Alizapride Daunorubicin Hydrochloride Air, Medicinal Dabigatran Mosliciguat Etrumadenant More therapies…

    Learn about Your Condition

    Peripheral spondyloarthritis Embolism Bladder cancer Lip and/or oral cavity cancer Diverticulitis Vaginal infection Metastatic neoplasm Gastric cancer stage IV Alcohol abuse Bile acid synthesis disorder Metastases to liver Follicular thyroid cancer Hepato-lenticular degeneration Haemorrhage Hot flush More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefuroxime
    • Metronidazole
    The Netherlands

  • Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Daratumumab
    Belgium Czechia France Germany Greece Italy +3

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Zanidatamab
    • Calcium Folinate
    Belgium France Germany Italy Spain

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Thrombocytopenia
    Investigated Drugs:
    • Netupitant
    • Pacritinib
    • Aprepitant
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Andersen-Tawil syndrome
    • Arrhythmia
    Investigated Drugs:
    • Atenolol
    • Bisoprolol Fumarate
    • Chlortalidone
    The Netherlands
Previous Page
1 … 500 501 502 503 504 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!